Molecular Pharmacology Program

The Steven Larson Lab

Research

Pictured: Steven Larson
Steven M. Larson, MD

My laboratory’s primary expertise is in molecular imaging, targeted radio diagnosis, and therapy using small molecules and monoclonal antibodies.

Currently, I am corresponding primary investigator of Memorial Sloan Ketterings’s In Vivo Cellular and Molecular Imaging Center (ICMIC) and coleader, with Ingo Mellinghoff and Charles Sawyers, of Research Project 4, studying molecular imaging correlates and biology of activation of the AR-axis in castrate-resistant prostate cancer. This project builds on extensive prior imaging collaborations with prostate cancer specialists Howard Scher, Michael Morris, and Peter Scardino and has led to the development of molecular imaging approaches to androgen receptor (AR) imaging as well as several novel radioantibodies that image downstream effectors of AR signaling.

View Lab Overview

Research Projects

Steven Larson Lab Group

Publications

View All Publications

People

Pictured: Steven Larson

Steven M. Larson, MD

  • Nuclear medicine physician Steven Larson focuses on molecular imaging in animals and humans using high-resolution diagnostic instruments, such as positron emission tomography, and single photon emission tomography.
  • MD, University of Washington School of Medicine (Seattle)
[email protected]
Email Address
646-888-3592
Office Phone
View physician profile
Physician profile

Members

Steven Larson
Steven Larson

Attending/Member

Daniela Burnes Vargas
Daniela Burnes Vargas

Research Technician

Jorge Carrasquillo, MD
Jorge Carrasquillo

Attending/Member PI

Chris Chandler
Sarah Cheal
Sarah M. Cheal

Senior Research Scientist

Teja Kalidindi
Teja Kalidindi

Research Assistant

Sang Gyu Lee
Sang Gyu Lee

Senior Research Scientist

Valerie Longo
Valerie Longo

Operations Coordinator

Neeta Pandit-Taskar
Neeta Pandit-Taskar

Attending, Molecular Imaging and Therapy Service, Department of Radiology; Member, Memorial Hospital; Professor, Dept. of Radiology, Weill Cornell; Clinical Director, Center for Radioimmunotargeted Imaging and Theranostics of the Ludwig Center for Cancer

Blesida Punzalan
Blesida Punzalan

Research Assistant

Shutian Ruan
Shutian Ruan

Senior Research Scientist

Darren Veach
Darren Veach

Assistant Attending Chemist

Lilly (Jiong) Wu
Lilly (Jiong) Wu

Senior Research Technician

Pat Zanzonico, PhD
Pat Zanzonico

Attending/Member

Lab Alumni
Julio Arevalo-Perez, MD, PhD
Julio Arevalo-Perez

Radiology Fellow

Meghan Bell
Meghan Bell

Research Technician

Marlene Camacho-Rivera
Edward Fung
Edward Fung

Research Scholar

Kishore Gangangari
Kishore Gangangari

Graduate Research Assistant with Hunter College CUNY

Somali Gavane
Somali Gavane

Fellow

Brendan Huang
Brendan Huang

Research Technician

Mitesh Patel
Mitesh Patel

Sr. Research Technician

Nagavara-Kishore Pillarsetty
Nagavara-Kishore Pillarsetty

Associate Attending Radiochemist

Ahmad Shariftabrizi

Graduate Medical Education

Hans David Ulmert, MD, PhD
Hans David Ulmert

Sr. Research Scientist

Xiaosun Zhou, MD
Xiaosun Zhou
Gregor Forster

Research Fellow

John Humm
John Humm

Member

Bipin Mehta

Assistant Laboratory Member

Lab Affilations

Open Positions

Postdoctoral Fellowship

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Steven M. Larson discloses the following relationships and financial interests:

  • Cardinal Health
    Provision of Services (uncompensated)
  • Elucida Oncology
    Intellectual Property Rights; Ownership / Equity Interests
  • Fonds de recherche du Quebec
    Provision of Services
  • Samus Therapeutics LLC
    Intellectual Property Rights
  • Voreyda
    Ownership / Equity Interests
  • Y-mAbs Therapeutics, Inc.
    Intellectual Property Rights; Ownership / Equity Interests

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures